Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04559425

Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

Sponsor: The Hospital for Sick Children

View on ClinicalTrials.gov

Summary

Few studies are specifically designed to address health concerns that are already relevant during pregnancy. The consequence is a lack of evidence on best clinical practice. This includes mothers and their babies when pregnancy is complicated by an abnormally slow heart rate due to maternal antibody-mediated heart disease in the unborn baby (fetus). Since the late seventies, it has been possible to detect and monitor fetal disease by ultrasound images and to treat selected conditions with pharmaceuticals administered via the mother. To this day, physicians need to make decisions about the management of such pregnancies without evidence from prospective clinical trials on drug efficacy and safety. The SLOW HEART REGISTRY is a multi-centered prospective observational study that will address the knowledge gap to guide future management of high-degree immune-mediated heart block to the best of care. The study seeks to establish an international database of the management and outcome of affected fetuses, to be used to publish information on the results of currently available prenatal care and to evaluate the need for additional research.

Official title: Slow Heart Registry: A Prospective Observational Cohort Study of Fetal Immune-mediated High Degree Heart Block

Key Details

Gender

FEMALE

Age Range

16 Years - 50 Years

Study Type

OBSERVATIONAL

Enrollment

350

Start Date

2020-01-01

Completion Date

2029-12-31

Last Updated

2024-05-22

Healthy Volunteers

Not specified

Interventions

DRUG

Dexamethasone

All management decisions are made by the primary physician and may include: 1) no treatment with dexamethasone or 2) treatment with dexamethasone from the time of enrollment

OTHER

No Dexamethasone

All management decisions are made by the primary physician and may include: 1) no treatment with dexamethasone or 2) treatment with dexamethasone from the time of enrollment

Locations (27)

Phoenix Children's Hospital

Phoenix, Arizona, United States

University of California San Francisco

San Francisco, California, United States

Children's Hospital Colorado

Denver, Colorado, United States

Children's National Medical Center

Washington D.C., District of Columbia, United States

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, United States

Children's Mercy Kansas City

Kansas City, Kansas, United States

Boston Children's Hospital

Boston, Massachusetts, United States

The Children's Heart Clinic/Children's Minnesota

Minneapolis, Minnesota, United States

Columbia University (New York)

New York, New York, United States

Texas Children's Hospital

Houston, Texas, United States

Seattle Children's Hospital

Seattle, Washington, United States

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

National Heart Hospital

Sofia, Bulgaria

IWK Nova Scotia Health

Halifax, Nova Scotia, Canada

The Hospital for Sick Children

Toronto, Canada

Hospital District of Helsinki and Uusimaa

Helsinki, Finland

Grenoble University Hospital

Grenoble, France

University of Bonn

Bonn, Germany

Hong Kong Children's Hospital

Ngau Tau Kok, Hong Kong

Kanagawa Children's Medical Center

Kanagawa, Japan

Shizuoka Children's Hospital

Shizuoka, Japan

Leiden University Medical Center - LUMC

Leiden, Netherlands

Centre of Postgraduate Medical Education Poland

Warsaw, Poland

Queen Silvia Children's Hospital

Gothenburg, Sweden

Skane University Hospital in Lund

Lund, Sweden

Karolinska University Hospital, Astrid Lindgen Childrens Hospital

Solna, Sweden

Taiji Clinic

Taipei, Taiwan